News and Trends 9 Oct 2015
TauRX, the leading Alzheimer-focused Biotech, earns funding after Phase II breakthrough
The Tau protein has already been implicated in the onset of Alzheimer's, with many biotechs on the hunt for a preventative therapy. Now, a University of Aberdeen (UK) associated biotech,…